O
Oncomfort
Health Tech & Medtech · Wavre, Belgium · Founded 2017
Virtual reality digital sedation for medical procedures MoreLess
Oncomfort was a Belgian-based developer of a digital sedation device for managing patient pain and anxiety before, during, and after medical procedures. Founded in 2017 by Diane Jooris, Mario Huyghe, and Julien Tesse, the company created a non-pharmacological therapy that combines clinical hypnosis and integrative therapeutic techniques using virtual reality. This approach aimed to reduce the need for medications and improve patient comfort and outcomes.
Co-founder Diane Jooris, who served as Chief Scientific Officer, has a background in clinical psychology and law, and practiced clinical hypnosis at the MD Anderson Cancer Center. Her experience helping cancer patients manage anxiety during invasive procedures inspired her to develop a more scalable, automated tool for hypnotherapy. Co-founder Mario Huyghe, who acted as CEO, has over two decades of experience in the healthcare business and eHealth sectors.
The company's core product, the Sedakit™, was a portable, all-in-one medical device that included a VR headset and provided a library of therapeutic sessions tailored to different patient needs, ages, and medical contexts, available in 12 languages. It was designed for use in various clinical fields, including anesthesia, oncology, interventional radiology, cardiology, and pediatrics. Clinical studies indicated that the digital sedation method could reduce procedure times, decrease involuntary movements, and in 80% of certain orthopedic surgeries, replace the sedative drug midazolam.
In September 2020, Oncomfort secured a €10 million ($11.8M) Series A funding round co-led by Debiopharm and Crédit Mutuel Innovation to advance product development and accelerate international expansion into European and American markets. The company gained a CE mark for its device in June 2018 and, by late 2020, had treated over 60,000 patients. In October 2023, Oncomfort was acquired by HypnoVR, a French competitor in the VR-based medical hypnosis space. The acquisition was intended to consolidate HypnoVR's market leadership in Europe and ensure the continued development and availability of Oncomfort's technology, which is now integrated into HypnoVR's offerings.
Keywords: digital sedation, virtual reality therapy, non-pharmacological pain relief, medical hypnosis, patient anxiety management, VR medical device, clinical hypnosis, digital therapeutics, medtech, pain management, anxiety relief, surgical support, interventional radiology, oncology patient support, pediatric sedation, non-invasive therapy, alternative to sedation, therapeutic VR, healthcare innovation, medical device
Company overview
Oncomfort company information
The essential company record, classifications and operating signals in one place.
- Status
- Acquired
- Founded
- 2017
- Headquarters
- Wavre, Belgium
- Employees
- 1
- Open positions
- None listed
- Dealroom signal
- 59.1
Valuation & funding
Oncomfort funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Oct 2023 | $0 | — | Hypno VR | ↗ |
| SERIES A✓Equity / VC | Sep 2020 | $11M | $44M | WE Venture · Crédit Mutuel Innovation · Debiopharm Group · Crédit Mutuel Equity | ↗ |
| SEED✓Equity / VC | Sep 2018 | $1.9M | $7.5M | BAN Flanders · WE Venture · Be Angels | — |
| SEED✓Equity / VC | Apr 2017 | $1.1M | $4.3M | Undisclosed | — |
Financials
Revenue, earnings and profit over time
Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.
| Year | EBITDA | Margin | Profit | Margin |
|---|---|---|---|---|
| 2026 | −$1.4M | — | −$1.8M | — |
| 2025 | −$1.4M | — | −$1.8M | — |
| 2024 | −$1.4M | — | −$1.8M | — |
| 2023 | −$1.4M | — | ||
| 2022 | −$1.4M | — | ||
| 2021 | −$1.4M | — | ||
| 2020 | −$1.1M | — |
Growth signals
Oncomfort website traffic
Latest recorded traffic for Oncomfort is 50 monthly website visits, down 95.8% over the last three months. Oncomfort's team declined 75% over the past year.
Comparisons
Oncomfort compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Oncomfort's talent
Source: Dealroom Talent Intelligence.
Investors
8 investors on Oncomfort's cap table
Sourced from Dealroom's funding and investor records.








Global footprint
Where Oncomfort has talent and traffic
team presence
In the news
Latest news about Oncomfort
Recent press, funding announcements, and product moves mentioning Oncomfort — open to read from the original sources.
Market sentiment
What the market is saying about Oncomfort
An AI-synthesized read of the highest-engagement posts about Oncomfort on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Oncomfort’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







